Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Aoshima (Kamogawa, Japan), K. Nakashima (Kamogawa, Japan), M. Yaegashi (Kamogawa, Japan), . Shiraishi (Kamogawa, Japan). Verifying the antibiotic selection algorithm in the new Japanese pneumonia guidelines - Is algorithm-discordant treatment associated with increased mortality of healthcare-associated pneumonia?. 2625

Member's Comments

No comment yet.

Related content which might interest you: Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008 Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011 Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines Source: Eur Respir J 2003 Dec 01;22(6):876-882 Year: 2003 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Impact of guidelines on HAP and VAP outcomes Source: Eur Respir Mon 2011; 53: 66-73 Year: 2011 Management of community-acquired pneumonia: new evidence-based algorithms. Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Use of a specific risk prediction rule for the hospital management of patients with community-acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003 Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 VAP: approach to therapy Source: Eur Respir Mon 2011; 53: 36-47 Year: 2011 Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia Source: Eur Respir J 2009; 33: 394-400 Year: 2009 Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis Source: Eur Respir J 2012; 39: 611-618 Year: 2012 Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 The success rates in community-acquired pneumonia treated consistently or inconsistently with the Turkish thoracic society pneumonia guidelines Source: Eur Respir J 2001; 18: Suppl. 33, 464s Year: 2001 Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Source: Eur Respir J 2006; 27: 158-164 Year: 2006